# A Clinical Trial of TQC2938 Injection in Healthy Adult Subjects

> **NCT06449859** · PHASE1 · UNKNOWN · sponsor: **Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.** · enrollment: 84 (estimated)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** TQC2938 Injection
- **DRUG:** TQC2938 Placebo

## Key facts

- **NCT ID:** NCT06449859
- **Lead sponsor:** Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-06-13
- **Primary completion:** 2024-11
- **Final completion:** 2024-11
- **Target enrollment:** 84 (ESTIMATED)
- **Last updated:** 2024-06-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06449859

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06449859, "A Clinical Trial of TQC2938 Injection in Healthy Adult Subjects". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT06449859. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*